top of page
Doctor-Reviewed Health Guides: Conditions, Procedures & Health News
Plain-language guides to diseases, conditions and medical procedures, plus the latest health research. Every article is medically reviewed by Dr. Baraa Alnahhal, MD.
Find diseases & conditions by first letter
Want another health topic explained?


Blood-Pressure Gap in Antenatal Care Across 72 Countries
The blood-pressure gap in antenatal care is the percentage of women who received antenatal care for their most recent birth and did not have their blood pressure measured during that care. Across 48 countries with surveys from 2015 to 2025, the median gap is 4.3% (interquartile range 1.9% to 10.3%).

Dr. Baraa Alnahhal
Nov 1216 min read


Plozasiran Lowers Triglycerides and Acute Pancreatitis Risk
Plozasiran is a small interfering RNA medicine that targets APOC3 messenger RNA to lower blood triglycerides and reduce the risk of acute pancreatitis in adults with severe hypertriglyceridemia, defined as fasting triglycerides of 500 mg/dL or higher. Seek emergency care for sudden, severe upper abdominal pain, nausea, or vomiting.

Dr. Baraa Alnahhal
Nov 98 min read


Ultra-Processed Foods and Brain Health: What a New MRI Study Found
Ultra-processed foods were linked to silent blood-vessel damage in the brain in a study published October 15, 2026. Among 8,783 Canadian adults aged 35 to 69 without heart disease, those who ate the most had 40% higher odds than those who ate the least, but did not score worse on memory tests. The study shows a link, not proof.

Dr. Baraa Alnahhal
Oct 197 min read


Pennsylvania Measles Outbreak: 1,222 Cases and What to Know
The Pennsylvania measles outbreak has reached 1,222 confirmed cases across 42 counties, with 225 people hospitalized and 5 confirmed measles-associated deaths, as of the October 14, 2026 state update. Almost every case was in unvaccinated people. The most important step is making sure your family has had two doses of the MMR vaccine.

Dr. Baraa Alnahhal
Oct 167 min read


Body Changes During Menopause Happen Suddenly, Study of 1 Million Women Finds
Body changes during menopause may happen suddenly rather than gradually. A study published October 12, 2026, of more than 300 million routine lab tests from over 1 million women found a step-like shift in hormones, bones, liver, kidneys and blood fats around the final menstrual period. Hormone changes started more than a decade earlier.

Dr. Baraa Alnahhal
Oct 157 min read


Dementia Risk: New Cases Could Double Worldwide by 2050
Dementia risk varies around the world. An analysis published October 12, 2026, found that about 10 in every 1,000 older adults develop dementia each year, with higher rates in women and in low- and middle-income countries. New cases could rise from about 11.4 million in 2023 to 24.7 million a year by 2050.

Dr. Baraa Alnahhal
Oct 147 min read


Statins and Glaucoma: What a Study of 210,000+ Adults Found
Statins were linked to a lower risk of glaucoma in a large study. Adults over 40 who took statins were 15% less likely to be diagnosed with open-angle glaucoma over five years than similar adults who did not. The study was observational, so it shows a link, not proof, and older research is mixed.

Dr. Baraa Alnahhal
Oct 137 min read


Semaglutide Vision Loss: What the Research Says About NAION Risk
Semaglutide vision loss refers to NAION, a rare eye condition reported in some people taking semaglutide. Observational studies link the drug to a higher risk, mainly in people with type 2 diabetes, but it may affect up to 1 in 10,000 users. Randomized trials have not confirmed a clear increase, and no study has proven the drug causes it.

Dr. Baraa Alnahhal
Oct 128 min read


Cash Incentives to Quit Smoking About Doubled Quit Rates in a Large Trial
Cash incentives to quit smoking about doubled quit rates in a large randomized trial. Among more than 3,200 adults who smoked and were referred for lung cancer screening, up to $600 in rewards plus free quit-smoking medicines raised verified six-month quit rates to 8.8%, compared with 4.3% for usual care. Most people still did not quit.

Dr. Baraa Alnahhal
Oct 97 min read


Pregnancy Complications and Heart Disease: What a Study of 1.4 Million Women Found
Pregnancy complications are linked to later heart disease, according to a study of more than 1.4 million women in England. Women who had high blood pressure in pregnancy, preeclampsia, gestational diabetes or postnatal depression were more likely to develop high blood pressure, type 2 diabetes, chronic kidney disease or cardiovascular disease. The study does not show cause.

Dr. Baraa Alnahhal
Oct 87 min read


Hot Flashes Treatment: New Guideline Puts Hormone Therapy First
Hot flash treatment guidance from the American College of Physicians recommends estrogen-based hormone therapy as the first choice for most women with bothersome hot flashes and night sweats, plus a progestogen if the uterus is present. Non-hormonal medicines such as venlafaxine, SSRIs, gabapentin or fezolinetant are later options. Some medical histories, such as breast cancer, may rule out hormones.

Dr. Baraa Alnahhal
Oct 76 min read


Diet Drinks and Weight Loss: What a 2-Year Trial Found vs Water
Diet drinks and water produced similar weight loss in a two-year randomized trial of 493 adults with overweight or obesity: 4.8 kg with diet drinks versus 3.7 kg with water, a difference that was not statistically significant. The trial was industry-funded, and fewer than half completed the final year. Water remains the simplest zero-calorie choice, and wider research is mixed.

Dr. Baraa Alnahhal
Oct 67 min read


Foundayo Heart Safety: What the ACHIEVE-4 Trial Found in Type 2 Diabetes
Foundayo (orforglipron) is a once-daily GLP-1 pill that, in the two-year ACHIEVE-4 trial of 2,749 adults with type 2 diabetes and high heart risk, was no worse than insulin glargine at preventing major heart events. These occurred in 4.2% on the pill and 5.0% on insulin. Stomach side effects were common, and US approval covers weight management only.

Dr. Baraa Alnahhal
Oct 28 min read


Blood Pressure Medication Recall 2026: Full List and What to Do
The latest blood pressure medication recall in the United States covers about 13,567 bottles of chlorthalidone 25 mg tablets (lot RISA24002) that failed dissolution testing and may not release their full dose. The FDA classified it as a Class II recall on September 17, 2026. Do not stop your medication on your own; call your pharmacist.

Dr. Baraa Alnahhal
Sep 308 min read


Vitruvias Therapeutics Thyroid Tablet Recall: What to Know
The Vitruvias thyroid tablet recall covers lot 504950 of Thyroid Tablets, USP 30 mg, used for an underactive thyroid, because the tablets may be superpotent and contain more hormone than labeled. The FDA raised it to a Class I recall, its most serious level. Do not stop taking thyroid tablets on your own; ask your pharmacist to check your lot.

Dr. Baraa Alnahhal
Sep 307 min read


FDA Chlorthalidone Dissolution Testing Recall: What to Know
The chlorthalidone recall covers 13,567 bottles of chlorthalidone 25 mg blood pressure tablets from lot RISA24002 that failed dissolution specifications and may not release their medicine as expected. The FDA classified it as a Class II recall, meaning possible temporary or reversible effects. Do not stop taking chlorthalidone on your own; check your lot number with your pharmacist.

Dr. Baraa Alnahhal
Sep 307 min read


Heart Health: The Complete Plain-Language Guide
Heart health means keeping your heart and blood vessels working well to lower your risk of heart attack, stroke and heart failure. Heart disease is the leading cause of death for both men and women. Protective habits include eating well, moving more, avoiding nicotine, sleeping 7–9 hours and keeping weight, cholesterol, blood sugar and blood pressure healthy.

Dr. Baraa Alnahhal
Sep 309 min read


Retatrutide for Weight Loss: What the New Type 2 Diabetes Trial Found
Retatrutide produced major weight loss in people with type 2 diabetes in the phase 3 TRIUMPH-2 trial of 1,152 adults: those on the highest dose lost an average of 20.8% of body weight over 80 weeks, versus 4.0% on placebo. Side effects were mostly digestive. Retatrutide is not FDA-approved, and versions sold online are not legal medicines.

Dr. Baraa Alnahhal
Sep 308 min read


Smartphones and Eating Disorders: What a New Study of 8,957 Kids Found
Smartphone ownership at age 12 is linked to eating disorder symptoms in young teens: a US study of 8,957 young people found 12-year-old smartphone owners were more likely to report binge eating and weight-based self-worth by age 14. The study is observational and shows a link, not proof, and symptoms were self-reported rather than formal diagnoses.

Dr. Baraa Alnahhal
Sep 297 min read


Mini Stroke and Dementia: What a 113,000-Person Study Found
A mini stroke, or transient ischemic attack, may raise dementia risk: a study of 113,081 Ontario adults found a 75% higher risk of dementia diagnosis in the first year and 34% higher over up to 20 years. The study shows a link, not proof of cause. A TIA is a warning sign that needs medical help.

Dr. Baraa Alnahhal
Sep 288 min read


HRT and Blood Clots: Menopause Hormone Pills vs Patches in a Major 2026 Study
Menopause hormone pills and patches differ in blood clot risk: in a nationwide Danish observational study, hormone therapy taken as a pill was linked to higher rates of blood clots, stroke and heart attack, while patches and gels showed no overall increase. The absolute risks were small, and the study cannot prove causation. Discuss any change with your prescribing clinician.

Dr. Baraa Alnahhal
Sep 258 min read


Tylenol During Pregnancy: Is It Safe? What the Newest Research Actually Found
Tylenol (acetaminophen) use in pregnancy is not robustly linked to autism or ADHD by current evidence; a September 2026 umbrella review found the association weakened substantially once low-quality studies were excluded. It remains an appropriate first-line treatment when clinically indicated. Use the lowest effective dose for the shortest time, and do not change any medication without your obstetric provider.

Dr. Baraa Alnahhal
Sep 257 min read


Ultra-Processed Foods: What a Study of 8.8 Million People Actually Found
Ultra-processed foods were linked to higher rates of chronic disease and early death in the largest analysis to date, covering 51 studies and nearly 8.8 million adults. The highest intake was associated with 18% higher all-cause mortality. All studies were observational, showing association rather than proof of cause, and no safe threshold has been established, supporting reduced intake.

Dr. Baraa Alnahhal
Sep 257 min read


More REM Sleep Linked to Lower Risk of 83 Diseases: What a 95,000-Person Study Found
More REM sleep was linked to lower disease risk in a 2026 observational study of 95,559 UK adults, where more REM sleep was associated with lower risk of 83 diseases, including heart failure and dementia, over about nine years. The study shows a link, not causation. For most conditions, risk was lowest with 6 to 8 hours of sleep.

Dr. Baraa Alnahhal
Sep 257 min read
bottom of page